Komori
Pharmarise Holdings (2796) · PolicyReframed

Separating Decision-Making and Oversight From Business Execution Under a Holding Company Structure

First written in FY2016. 1 of 3 entries say "Restated". Latest entry: FY2020.

3entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2016 – FY20182016: 120162017: 020172018: 120182019: 020192020: 12020
Same theme, other companies
Functional Separation Between the Board of Directors and Executive Officers and Faster Decision-MakingA theme 392 companies write about · 0 as a headwind · 393 as a tailwind

Pharmarise Holdings moved to the "Worse" side of this theme in 2020, 2 years before the typical company in this theme (2022).

3 other companies' latest entry also says "Reframed".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 393 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2020ReframedAnnual report

    「Although we had separated responsibility for business execution from responsibility for oversight by introducing an executive officer system in October 2011, we determined that the strengthened Board of Directors alone could adequately perform both management decision-making and oversight and business execution, and therefore abolished the executive officer system and the Executive Officers' Meeting at a Board of Directors meeting held on 28 August 2019.」

    The structure was reorganized from functional separation under the executive officer system to one in which the strengthened Board of Directors alone handles decision-making and oversight as well as business execution.
  2. FY2018RestatedAnnual report

    「We separated the management decision-making and oversight functions previously handled by directors from the business execution function. Directors are responsible for management decision-making and oversight, while executive officers are responsible for business execution.」

    We continue to adopt group governance based on the separation of functions between directors and executive officers.
  3. FY2016First statedAnnual report

    「We separated the management decision-making and oversight functions previously handled by directors from the business execution function. Directors are responsible for management decision-making and oversight, while executive officers are responsible for business execution.」

    The executive officer system separates the Board’s oversight function from executive responsibility.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Pharmarise Holdings's next results are scheduled for 2026-09-17. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Separating Decision-Making and Oversight From Business Execution Under a Holding Company Structure | Pharmarise Holdings Corporation (2796) | Komori